Follow-up study of the treated cohort Clinical Trials
2 recruitingDrug
Phase 31
Showing 1–2 of 2 trials
Recruiting
Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma
CarcinomaCarcinoma, Renal CellNeoplasms+10 more
Jinling Hospital, China39 enrolled1 locationNCT06676527
Recruiting
Phase 3
Long-term Interventional Follow-up Study of Children With Prader-Willi Syndrome Included in the OTBB3 Clinical Trial
Prader-Willi Syndrome
University Hospital, Toulouse80 enrolled12 locationsNCT05032326